AstraZeneca COVID-19 Vaccine Trial Data Questioned By Safety Board
In an unusual post-midnight statement, the National Institute of Allergy and Infectious Diseases said AstraZeneca might have used old data for its COVID-19 vaccine trial.
Read more on NPR
No comments:
Post a Comment